Enterohaemorrhagic Escherichia coli (EHEC), serotype O157 : H7 is a non-invasive, pathogenic bacterium that employs a type III secretion system (T3SS) to inject effector proteins into infected cells. In this study, we demonstrate that EHEC blocks tumour necrosis factor-alpha (TNFa)-induced NF-kB signalling in infected epithelial cells. HEK293T and INT407 epithelial cells were challenged with EHEC prior to stimulation with TNFa. Using complementary techniques, stimulation with TNFa caused activation of NF-kB, as determined by luciferase reporter assay (increase in gene expression), Western blotting (phosphorylation of IkBa), immunofluorescence (p65 nuclear translocation) and immunoassay (CXCL-8 secretion), and each was blocked by EHEC O157 : H7 infection. In contrast, subversion of host cell signalling was not observed following exposure to either enteropathogenic E. coli, strain E2348/69 (O127 : H6) or the laboratory E. coli strain HB101. Heat-killed EHEC had no effect on NF-kB activation by TNFa. Inhibition was mediated, at least in part, by Shiga toxins and by the O157 plasmid, but not by the T3SS or flagellin, as demonstrated by using isogenic mutant strains. These findings indicate the potential for developing novel therapeutic targets to interrupt the infectious process.
INTRODUCTION
Disease burden associated with attaching and effacing enteric pathogens is high, with outbreaks occurring yearly around the world (Croxen & Finlay, 2010; Jay et al., 2007) . Enterohaemorrhagic Escherichia coli (EHEC), serotype O157 : H7 asymptomatically colonizes the gut of ruminants (La Ragione et al., 2009) , but is a zoonotic infection linked to both food-and water-borne outbreaks of diarrhoea and haemorrhagic colitis in humans. EHEC O157 : H7 infection is the primary cause of diarrhoea-associated haemolyticuraemic syndrome, primarily afflicting children and the elderly (Tarr et al., 2005) . The related organism, enteropathogenic E. coli (EPEC) primarily causes non-bloody protracted diarrhoea in children living in developing countries (Kaper et al., 2004) .
It is now well appreciated that enteric pathogens exploit host inflammatory responses to promote gut colonization (Pédron & Sansonetti, 2008) . EHEC O157 : H7 causes rearrangement of the infected cell cytoskeleton, leading to the development of attaching and effacing lesions on infected epithelial cells within 4-6 h (Sherman et al., 2010) . This non-invasive pathogen uses a type III secretion system (T3SS), encoded on the locus of enterocyte effacement (LEE) pathogenicity island, as a molecular syringe to inject multiple effector proteins that alter host cell signal transduction cascades. Both EHEC O157 : H7 and non-O157 : H7 Shiga toxin (Stx)-producing E. coli (STEC) subvert host-cell signalling to avoid recognition by the innate immune system (Pédron & Sansonetti, 2008) , including inhibiting tyrosine phosphorylation and activation of STAT-1 that is normally induced by IFN-c (Ceponis et al., 2003; Jandu et al., 2007) .
The NF-kB signalling pathway is another first-line, innate immune defence mechanism promoting protection against microbial pathogens (Hayden & Ghosh, 2008) . In nonstimulated cells, NF-kB subunits are sequestered in an inactive state in the cytosol by direct binding to the inhibitory molecules of kB (IkB). Activation following cytokine stimulation [such as by TNFa and interleukin (IL)-1b] leads to the phosphorylation and ultimate degradation of IkBa. This then releases the NF-kB active subunits (p65/p50), which translocate from the cytosol to the nucleus to activate transcription of multiple target genes. Among NF-kB target genes are an array of proinflammatory cytokines and chemokines, including CXCL-8 (formerly referred to as IL-8). Downstream production of pro-inflammatory mediators serves to control and, ultimately, clear the infectious insult.
Previous studies report that EHEC O157 : H7 both induces and inhibits inflammation (Bellmeyer et al., 2009; Berin et al., 2002; Hauf & Chakraborty, 2003; Ritchie et al., 2003) . Berin et al. (2002) described that infection of epithelial cells for 3 h with EHEC O157 : H7 leads to the activation of NF-kB via a flagellin-mediated mechanism. However, other studies suggest a dual response to EHEC O157 : H7 challenge, with shorter exposures (1 h) leading to NF-kB activation, but longer-term exposure (6 h) followed by stimulation with TNFa resulting in an inhibition of NF-kB signalling (Hauf & Chakraborty, 2003) . More recently, EHEC O157 : H7 has been reported to inhibit cytokine-induced production of CXCL-8 in an Stx-dependent manner (Bellmeyer et al., 2009) . Similarly, the non-LEE encoded effectors NleE (Nadler et al., 2010; Newton et al., 2010; Vossenkämper et al., 2010) and NleH (Royan et al., 2010; Wan et al., 2011) were reported to attenuate TNFa-induced NF-kB activation. Similar discordant findings are described with respect to EPEC infection and NF-kB activation (Nadler et al., 2010; Royan et al., 2010; Sampaio et al., 2009 ). The present study addresses the ongoing controversy in the field by determining whether EHEC O157 : H7 and EPEC cause inhibition of NF-kB following cytokine stimulation.
METHODS
Cell lines, bacterial strains and infection conditions. Human embryonic kidney (HEK293T) cells and human fetal intestinal epithelial (INT407) cells, both non-polarized cell lines, were utilized in this study. HEK293T cells were cultured in DMEM supplemented with 5 % fetal bovine serum (FBS), 100 U penicillin/streptomycin ml 21 , 1 % non-essential amino acids, 1 % glutamine and 1 % pyruvate (all from Invitrogen). INT407 cells were cultured in MEM supplemented with 10 % FBS and 100 U penicillin/streptomycin ml 21 . Cells were switched to antibiotic-free medium at least 24 h prior to infection. Bacterial strains employed in these studies are shown in Table 1 . Isogenic mutants were created and used to determine the underlying mechanisms of action of EHEC. An NleH mutant strain (and parental strain; 85-170 Nal r ) were kindly provided by Dr Gad Frankel (Imperial College London, England). Non-O157 : H7 STEC, including strains CL9 (serotype O26 : H11) and CL15 (O113 : H21) (Jandu et al., 2007) and EPEC strain E2348/69 (O127 : H6) were used for comparative purposes. An evolutionary intermediate strain between EPEC and EHEC (serotype O55; DEC5B) was also tested (Leopold et al., 2009 ).
E. coli strains were cultured on blood agar overnight. Colonies were then picked from the plate and grown overnight at 37 uC, without shaking, in 10 ml Penassay broth. For heat-killing of organisms, an overnight bacterial culture was placed in boiling water for 1 h. To ensure that organisms had not survived, an aliquot was streaked onto blood agar plates and grown overnight at 37 uC and then checked for colony growth. To obtain bacteria-free supernatants, an overnight culture was centrifuged for 10 min at 3000 g and the supernatant was collected and filtered through 0.2 mm filters (Pall). For m.o.i. studies, the total volume of bacteria added to each well was reduced accordingly.
Isogenic mutants. Isogenic mutants were generated from EHEC O157 : H7, strain EDL933 using a one-step inactivation technique (Datsenko & Wanner, 2000) . Briefly, EDL933 was transformed with pKD46 and l Red recombinase expression was induced with Larabinose at 30 uC on a shaker and then made electrocompetent. Linear DNA fragments were generated using PCR with primers listed in Table 2 on plasmid pKD4 (template plasmid with FLP recognition target sites flanking a kanamycin resistance gene). PCR products were generated by using primers designed to include ends of the gene. EDL933 transformants containing pKD46 were electroporated with purified linear PCR fragments and mutants were confirmed using the respective primers, indicated by a shift in the product size from 1.7 kb (the gene of interest) to 1.5 kb (containing the kanamycin cassette).
To generate a pO157 mutant, E. coli O157 : H7, strain EDL933 was cured of the pO157 plasmid using the Plasgene pCURE2 kit (Plasgene). Briefly, EDL933 was transformed with pCURE2 and selected on LB kanamycin (50 mg ml 21 ) overnight at 37 uC. Transformants were then incubated overnight at 37 uC in LB containing 5 % sucrose to remove the pCURE2 plasmid. Resulting transformants were confirmed to be kanamycin-sensitive by streaking onto LB kanamycin plates and verified by PCR to have lost the pO157 plasmid. Double pO157/stx1 and stx2 mutants were created by using the pO157 mutant, removing the pCURE2 plasmid and independently deleting each of the stx genes. Verification was performed by using PCR.
The stx1A and stx2A mutants were complemented in trans using the pBAD-TOPO TA cloning kit (Invitrogen) containing either stx1A or stx2A under control of an arabinose promoter. Briefly, stx1A and the stx2A genes were amplified by PCR using primers listed in Table 2 . All constructs were verified using PCR and DNA sequencing (The Centre for Applied Genomics, Hospital for Sick Children, Toronto, Ontario, Canada). Genes were induced in the complements with 0.02 or 0.002 % arabinose (determined using a dose-response curve) while growth was verified by measuring optical density (600 nm) in broth cultures. 
Primer name
Sequence (5 §-3 §) ). Following incubation (4 h at 37 uC) with the proinflammatory cytokine, cells were lysed with passive lysis buffer and assessed for luminescence using a plate reader (Victor 3 reader, Perkin Elmer). Luminescence assays were performed in triplicate and normalized to control (unstimulated, uninfected) cells, with results reported as fold increase over control. Independent experiments were performed, in triplicate, at least three times. Eukaryotic cell viability was confirmed using trypan blue exclusion and b-galactosidase activity, both of which showed no differences in infected cells compared with uninfected controls.
Immunofluorescence for p65. INT407 cells were utilized because HEK293T cells easily lift off plastic surfaces, especially following challenge with microbial pathogens. Cells were seeded onto plastic chamber slides (Lab Tek) overnight (5610 5 cells per well). Subconfluent cell monolayers were challenged with bacteria for 2 h at 37 uC and then treated with TNFa (100 ng ml
21
) for 30 min at 37 uC. Formalin-fixed cells (30 min; room temperature) were subsequently permeabilized with Triton X-100 (5 min at 25 uC), washed and blocked with 1 % BSA (Sigma) for 30 min at room temperature. Primary antibody (p65; Santa Cruz) (1 : 500) was added for 1 h at 25 uC. After washing, a fluorochrome-coupled secondary antibody was added for 1 h [Cy2 goat anti-rabbit, 1 : 1000 (Jackson Immunoresearch)], followed by 5 min treatment with DAPI (1 : 36000; Invitrogen) to stain the cell nucleus. Slides were visualized using a fluorescence microscope (Leica) attached to a digital camera for image capture (2006 magnification).
IkB kinase (IKK) activity assay. INT407 cells were seeded into sixwell plates and grown to subconfluence. Infection with EHEC O157 : H7, strain CL56 was performed for 2 h at 37 uC, followed by stimulation with TNFa (100 ng ml 21 ; 5 min). Cells were then washed with ice-cold PBS (Gibco) and lysed using radio-immunoprecipitation assay (RIPA) buffer to obtain whole-cell protein extracts. Cell extracts were centrifuged (5 min at 15 000 g) and supernatants collected and stored at 280 uC. Protein concentration was determined by using the Bradford assay. The IKK complex was pulled down by a specific IKKc immunoprecipitation (IP). IP was performed using anti-IKKc (Santa Cruz). IP consistency was controlled by immunoblotting for co-immunoprecipitated IKKb (anti-IKKa/b, Santa Cruz) as a loading control. IKK activity was measured by in vitro phosphorylation of recombinant GST:IkBa 1-100 , as described previously (Brenner et al., 2009) .
Western blotting for IkBa and phospho-IkBa. Cell extracts were collected, as described above for the IKK assay. Lysates containing SDS-PAGE loading buffer were boiled (3 min) and 20 mg protein was loaded into precast, 10 % polyacrylamide gels (BioRad) for electrophoresis (120 V; 1.5 h). Proteins were transferred onto nitrocellulose (100 V; 4 uC; 1 h) and membranes were blocked (1 h at room temperature) using Odyssey blocking buffer (LICOR Biosciences). Membranes were then incubated in primary antibodies (b-actin, IkBa and phospho-IkBa at 1 : 1000 dilutions; Cell Signalling) overnight in Odyssey blocking buffer plus 0.1 % Tween. After washes in PBS plus 0.1 % Tween, membranes were incubated with a fluorescent secondary antibody (IRDye 800 goat anti-rabbit IgG [Rockland Immunochemicals] and Alexa Fluor 680 goat anti-mouse IgG [Molecular Probes]; 1 : 10 000) in Odyssey blocking buffer plus Tween for 1 h. This allowed for simultaneous probing for both IkBa (IRDye 800) and phospho-IkBa (IRDye 700). Immunoblots were scanned and visualized using the Odyssey imaging system (LICOR Biosciences).
Chemokine and cytokine measurements. Supernatants from cells challenged with EHEC O157 : H7 strain CL56 for 2 h and stimulated with TNFa (100 ng ml 21 for 6 h) were collected. Following centrifugation to remove dead cells and debris, levels of CXCL-8 and TNFa were then assessed in supernatants. Protein concentrations were determined using an electrochemiluminescence detection system (Mesoscale Discovery).
Statistics. Results are expressed as means±SE. Where applicable, groups were compared using Student's t-test, analysis of variance (ANOVA) or Mann-Whitney test (non-parametric). Analyses were performed using InStat3 and Prism4 (GraphPad). Differences of P,0.05 were considered significant.
RESULTS EHEC O157 : H7 prevents TNFa-induced NF-kB activation
Inoculation with the non-pathogenic E. coli HB101 causes activation of the NF-kB signalling cascade, in contrast to the pathogenic strain, EHEC. Stimulation with TNFa caused activation of the NF-kB signalling cascade, indicated by increased NF-kB-dependent luciferase production, compared with unstimulated, uninfected cells (Fig. 1a) . Challenge (6 h) with strain HB101 caused increased luciferase expression, which was not observed following infection with EHEC. Luciferase expression was significantly reduced in cells challenged with EHEC, but not HB101, for 2 h prior to TNFa stimulation, indicating that the inhibition of TNFa-elicited NF-kB-dependent gene transcription was due to the presence of the enteric pathogen. Similar inhibition of NF-kB-driven luciferase expression was observed following IL-1b stimulation (Fig.  1a) , indicating that the finding was not unique to TNFaelicited signal transduction responses. Titration of EHEC revealed a dose-dependent inhibition of TNFa-induced NF-kB activation (Fig. 1b) .
In the basal state, heat-killed EHEC and culture supernatant elicited activation of NF-kB signalling, in contrast with live bacteria which blocked NF-kB activation. Similar to previous studies involving STAT signalling (Jandu et al., 2006) , heat-killed EHEC O157 : H7 and filtered sterile culture supernatants showed no blockage of TNFa-induced activation of NF-kB (Fig. 1c) , indicating that live bacteria were required for EHEC O157 : H7 inhibition of cytokineinduced activation of NF-kB. Subversion of host-cell signalling by EHEC was not unique to the NF-kB transcription factor, as demonstrated by inhibition of PMA-induced activation of AP-1 signalling (Fig. 1d) .
To assess the time-course of EHEC blockage of NF-kB, cells were pre-treated with EHEC from 0 to 2 h, prior to stimulation with TNFa. Pre-treatment with EHEC for 1 h, but not 30 min, was sufficient to completely block TNFainduced NF-kB signalling (Fig. 1e) . These results indicate a profound effect of EHEC challenge on a major intracellular signal transduction cascade.
EHEC blocks TNFa-induced chemokine secretion
TNFa initiates the production of several cytokines and chemokines that are implicated in the clearance of bacterial infections. To investigate the effect of EHEC O157 : H7 infection on host-chemokine expression, CXCL-8 production following TNFa stimulation was assessed from both uninfected and EHEC O157 : H7-infected cells. As expected, TNFa stimulation increased chemokine production in uninfected controls (TNFa; 999.6±66.3* versus control; 491.9±13.5 pg ml 21 ; n53, *P,0.001), while EHEC O157 : H7, strain CL56 infection blocked TNFainduced CXCL-8 production in INT407 cells (577.3±20.6 pg ml 21 , n53, P,0.001 compared with TNFa stimulation). To ensure that inhibition of chemokine production by EHEC O157 : H7 was not related to direct breakdown of TNFa by the pathogen, the concentration of TNFa in supernatants following infection was measured at 8 h post-infection. Degradation of TNFa over time was not observed, ruling out proteosomal inactivation (control; 21±10 pg ml 21 ; TNFa; 75 356±21 000 pg ml 21 ; EHEC+TNFa; 44 582±1000 pg ml 21 ; n53). These data indicate that EHEC modulation of cytokine-elicited signalling was capable of disrupting the expression of endogenous NF-kB-dependent genes.
EHEC prevents nuclear translocation of p65 following stimulation with TNFa
To determine whether EHEC O157 : H7 challenge interfered with nuclear translocation of NF-kB, immunofluorescence microscopy was performed to assess translocation of the p65 subunit from the latent form in the cytosol to the nucleus. Under basal conditions, p65 was present in the cytoplasm of INT407 cells (Fig. 2a-c ) with stimulation with TNFa (100 ng ml
21
, 30 min) resulting in nuclear translocation of p65 (Fig. 2d-f ). This translocation of p65 was inhibited by 2 h of EHEC infection prior to cytokine stimulation ( Fig. 2g-i ). In contrast with EHEC, the laboratory E. coli strain HB101 did not prevent TNFainduced translocation of p65 to the nucleus (Fig. 2j-l) . This finding suggests an upstream effect of EHEC on the NF-kB signalling cascade. 
EHEC blocks IKK activity and subsequent phosphorylation of IkBa induced by TNFa
The influence of EHEC on IKK activity (Hayden & Ghosh, 2008) was measured by using an in vitro IKK assay. Under basal conditions, IKK activity was minimal ( Fig. 3a; lane 1) . Stimulation with TNFa (100 ng ml 21 , 5 min) resulted in a twofold increase in IKK activity ( Fig.  3a; lane 2), which was blocked by infection with EHEC O157 : H7 for 2 h (Fig. 3a; lane 4) . By contrast, EHEC infection alone had no impact on IKK activity ( Fig. 3a ; lane 3).
Western blotting was used to determine IkBa phosphorylation status. In non-stimulated INT407 cells, IkBa was present in its native, non-phosphorylated form (Fig. 3b,  ' ctrl' lane). Following stimulation with TNFa (100 ng ml
21
, 5 min), phosphorylation of IkBa (pIkBa) and degradation of IkBa was observed (Fig. 3b, middle O157 : H7 prevented phosphorylation and subsequent degradation of IkBa (Fig. 3b , right-hand lane). Blots were stripped and reprobed for b-actin. Taken together, these results show that infection with EHEC abrogates TNFadependent IKK activation and IkBa phosphorylation and degradation.
lane). Treatment with TNFa following 2 h infection with EHEC
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Subversion of epithelial cell signalling by EHEC is mediated, at least in part, by Stx1 and Stx2
To determine which EHEC virulence factor mediates NF-kB inhibition in HEK293T cells, isogenic mutants were generated. Using isogenic gene knockout mutants for multiple virulence factors, including the T3SS (espA, espB, espD, espF, espFU), tir, the type II secretion system (etpD) and flagellin (fliC) revealed that these were not involved in mediating the inhibitory effect of EHEC on NF-kB signalling. Each of these isogenic mutants demonstrated inhibition of NF-kB similar to wild-type EHEC O157 : H7, strain EDL933 (Fig. 4a) . In contrast, as shown in Fig. 4(b) , there was less inhibition of TNFa-mediated NF-kB activation in response to challenge with pO157 2/2 and stx1 and stx2 single and double deletion strains prior to stimulation with TNF-a. Complementation of stx1 and stx2 isogenic mutants restored the inhibitory effect, whereas double stx/ pO157 mutants partially restored TNFa-induced NF-kB activation, similar to the effects observed using single-gene knockouts (Fig. 4c) .
Recent studies report that subversion of host cell signalling by Shigella flexneri is mediated by the OspG protein, which prevents ubiquitination and degradation of phospo-IkBa (Kim et al., 2004) . Sequencing of E. coli O157 : H7 strain Sakai has shown that EHEC contains homologues of OspG, called NleH1 and NleH2 (Tobe et al., 2006) , which function as a T3SS effector. NleH1 binds to the NF-kB subunit ribosomal protein S3 (RPS3) to suppress an inflammatory response (Gao et al., 2009; Wan et al., 2011) . However, in contrast with these findings, in our hands an EHEC O157 : H7 isogenic mutant lacking both nleH1 and nleH2 did not cause TNFa-induced NF-kB activation (Fig.  4d) . Taken together, these results indicate that multiple factors contained within the O157 plasmid and through Shiga toxins mediate the inhibitory effect of EHEC on TNFa-induced NF-kB signalling.
Non-O157 STEC and EPEC do not subvert host cell signalling as efficiently as EHEC O157 : H7
Other strains of pathogenic E. coli, both Stx-positive and Stx-negative, were used to determine the extent of the ability of various pathogenic E. coli to inhibit cytokineinduced pro-inflammatory pathways in HEK293T cells. Non-O157 STEC strains are similar to EHEC genetically with respect to virulence factors . STEC strains CL9 (serotype O26:H11) and CL15 (O113:H21) disrupt host cell signalling in human epithelial cells (Ceponis et al., 2003; Jandu et al., 2007) . In contrast, in the present study both STEC strains responded differently compared with EHEC O157 : H7, with reduced inhibition of TNFa-induced NF-kB activation and more basal stimulation of this signal transduction pathway (Fig. 4e) . Similar to non-O157 : H7 strains, EPEC infection resulted in moderate NF-kB activation and less inhibition following cytokine simulation. In contrast, O55:H7, strain DEC5B (and O55, strain DEC5D, data not shown), which are considered to be ancestral intermediaries between EPEC and EHEC (Leopold et al., 2009) , disrupted host cell signalling as efficiently as O157 : H7. Taken together, these data indicate that signal transduction responses to various pathogenic E. coli strains are not always alike.
To determine whether the reduced inhibition by EPEC was due to altered kinetics of bacterial infection, a timecourse study was performed. Regardless of the timing of EPEC prior to stimulation with TNFa, inhibition of NF-kB signal transduction responses was not observed (Fig. 4f) .
DISCUSSION
Bacterial pathogens are known to manipulate host cell signalling cascades to promote their survival in the human intestine (Bulgin et al., 2009; Cheminay et al., 2005; Kim et al., 2005) . They are known to modulate the NF-kB signalling pathway by activation or inhibition, depending on individual life cycle requirements (Rahman & McFadden, 2011) . In the present study, EHEC infection of eukaryotic cells caused inhibition of both basal and TNFa-induced activation of the NF-kB signal transduction cascade, in contrast with a non-pathogenic E. coli strain, which activated basal NF-kB and was unable to block TNFainduced activation. This ability of EHEC to block signalling cascades probably resides within the multiple virulence factors it contains compared with non-pathogenic E. coli strains. Inhibition occurred at the level of IkBa phosphorylation, and this subversion of host cell signalling was observed only in the presence of live pathogenic bacteria. These studies further identified that inhibition was mediated, at least in part, by both the O157 plasmid and Shiga toxins, but not by the T3SS, H7 flagella or NleH virulence factors. This study also highlights, for the first time to our knowledge, that the ability of EHEC O157 : H7 to block TNFa-induced NF-kB signalling was acquired at some point after evolutionarily branching from EPEC.
To survive in the host, enteric bacterial pathogens subvert the pro-inflammatory signalling cascade that is an integral Fig. 4 . EHEC inhibition of TNFa-induced NF-kB activation is mediated, in part, by Stxs and the pO157 plasmid. (a-c) Isogenic EDL933 mutants [espA, espB, espB, espF, espFu, fliC, etpD and tir (a) ; and pO157, stx1, stx2, stx1/2 (b)] were generated. stx1 and stx2 mutants were complemented and double stx/pO157 gene deletion mutants were generated (c). (d) An nleH mutant and its wild-type strain 85-170NalR were also obtained to assess the role of nleH in mediating the inhibition of NF-kB signalling. Other pathogenic E. coli strains, including EPEC and non-O157 : H7 STEC strains (CL9 and CL15), were used for comparison (e). (f) A time-course was performed for EPEC infection and stimulation with TNFa. All groups were compared with uninfected, untreated controls (set to a value of 1); *P,0.05; one-way ANOVA compared with EHEC+TNFa; n54-6. Activation is given as the fold increase over the uninfected control. Bars: black, control; white, TNFa.
part of the host innate immune system (Pédron & Sansonetti, 2008) . Various enteric pathogens inhibit signal transduction cascades at different points in the NF-kB signal transduction cascade (Rahman & McFadden, 2011) . Shigella flexneri, for example, expresses a virulence factor, OspG, which prevents ubiquitination of phospho-IkBa, thereby negatively controlling innate immune responses (Kim et al., 2005) . EHEC blocks other signal transduction cascades, including, for example, interferon-cinduced STAT-1 activation in epithelial cells (Ceponis et al., 2003) .
To elucidate the mechanisms of action underlying EHEC O157 : H7 subversion of TNFa-induced NF-kB activation, various points in this signal transduction cascade were studied. Using complementary techniques, the findings in this study indicate that EHEC O157 : H7 inhibits the activity of IKK, blocking the phosphorylation of IkBa, which prevents the release of p65 in the cell cytosol and subsequent nuclear translocation. As a result, chemokine production and secretion is blocked.
In contrast with our findings, a previous study described EHEC infection of human intestinal epithelial cells for 3 h activating the NF-kB signalling pathway and inducing the production of CXCL-8 independent of Stx and intimin, but mediated by H7 flagellin (Berin et al., 2002) . Another research group reported that EHEC and EPEC both suppress TNFa-induced NF-kB activation after an initial induction phase (Hauf & Chakraborty, 2003) . In this case, inhibition was reported to be mediated by the bacterial factor EspB, a LEE-encoded T3SS protein which inserts into the host membrane to form a pore structure (Hauf & Chakraborty, 2003) . A more recent study describes a role for the T3SS protein NleH in binding to NF-kB proteins and inhibiting signalling (Gao et al., 2009) . However, this effect is not evident in all STEC strains, because STEC serotype O111:H 2 reduces TNFa-induced p65 translocation to the nucleus in an OspG-homologue-independent manner (Nobe et al., 2009) .
The varying results reported by multiple research groups can be explained, at least in part, by variations in the experimental techniques that have been utilized to measure NF-kB activation as well as in differences in the host cell lines employed, EHEC strains tested and the infectious challenge and TNFa exposure protocols employed. It is of interest now to determine whether a similar pattern is found in the in vivo setting, by employing a relevant animal model of human disease. EPEC, which is related evolutionarily to EHEC O157 : H7, does not contain Shiga toxins but does possess the LEE pathogenicity island and produces attaching and effacing lesions on eukaryotic cells in tissue culture exposed to the human enteric pathogen (Lapointe et al., 2009) . With respect to NF-kB signalling, previous studies have reported that EPEC inhibits IKK, MAPK and P-I3 kinase signal transduction pathways in a T3SS-dependent manner (Ruchaud-Sparagano et al., 2007). Another study described a role for EPEC-derived flagellin in early, but not late, chemokine production (Sampaio et al., 2009) . Similar to EHEC, EPEC also contains nleH, which has been shown to function to dampen the NF-kB pathway and facilitate colonization (Royan et al., 2010) . In the current study, we found that EPEC infection resulted in a moderate increase in basal NF-kB activation but produced only a modest inhibition of TNFa-induced activation of NF-kB. Taken together, these findings indicate that EPEC and EHEC O157 : H7 behave differently with respect to NF-kB signal transduction responses.
A more recent study reported that EHEC O157 : H7 suppresses the inflammatory response to both cytokines and Stxs (Bellmeyer et al., 2009) . In this case, inhibition of chemokine production by both TNFa and IL-1b stimulation and the role of Stx in mediating these effects were similar to the findings presented in our study. Using isogenic EDL933 stx1, -2 and -1/2 mutants, we found that there was a reduced inhibition of TNFa-induced NF-kB activation compared with wild-type EHEC O157 : H7, which was restored following complementation of mutant strains. The lack of an additive effect observed between the two stx-deleted strains can be explained, at least in part, by varying roles of the toxins in infection (Stearns-Kurosawa et al., 2010) . Such variations in host responses may involve different signal transduction pathways and account for a lack of a cumulative effect observed in the reductionist tissue culture model system employed in the current experiments. Previous studies have demonstrated a role for Stxs in contributing to EHEC-induced responses to NF-kB but did not discern any differences between Stx1 and Stx2 (Bellmeyer et al., 2009) . The lack of a response to culture supernatant, which contains both secreted toxins, can be explained in part by the lack of expression of the Gb3 receptor in Hek293T cells. Similar findings were observed by Bellmeyer et al. (2009) where culture supernatant, regardless of the presence of Stx, failed to inhibit chemokine secretion.
Taken together, the findings presented in this study demonstrate that EHEC O157 : H7 blocks cytokineinduced activation of the NF-kB signal transduction cascade in host epithelial cells at the level of the IKK complex. Knowledge about EHEC O157 : H7 inhibition of a critical host innate immune response should be exploited in the future development of novel treatment options for use in patients infected with this enteric pathogen.
